Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$3.59 USD
-0.06 (-1.64%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $3.54 -0.05 (-1.39%) 4:34 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Galectin Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GALT 3.59 -0.06(-1.64%)
Will GALT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GALT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GALT
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
Here's Why Galectin Therapeutics (GALT) is Poised for a Turnaround After Losing -31.83% in 4 Weeks
GALT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for GALT
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names
Director’s Bold Move: Major Stock Purchase at Galectin Therapeutics!
Largest borrow rate increases among liquid names
12 Health Care Stocks Moving In Friday's After-Market Session